
Cooper Companies (COO) Stock Forecast & Price Target
Cooper Companies (COO) Analyst Ratings
Bulls say
Cooper Companies is a leading eyecare company that offers a diverse portfolio of both contact lens and medical device products through its two segments, CooperVision and CooperSurgical. Despite potential challenges in revenue and growth in the short term, there is room for optimism in the longer-term with easier comparables, a strengthening pricing environment, and potential value unlocking through a strategic review. However, potential risks such as increasing competition, consumer weakness, investments, and currency headwinds should also be considered.
Bears say
Cooper Companies is facing softer results in the contact lens market due to a sequential deceleration in growth, with its peers also reporting similar trends. While its myopia management segment is expected to contribute to organic growth, the discontinuation of fitting sets for their legacy product may mean that the company won't adopt a tiered pricing strategy, potentially resulting in lower revenue. Additionally, the decision to discontinue fitting sets may also signal a move away from a private label strategy, which could limit potential revenue growth opportunities. Based on the current industry trends and potential pricing and product positioning challenges, it is likely that Cooper Companies will face margin pressures in the future, negatively impacting its profitability and ultimately leading to a negative outlook for the stock.
This aggregate rating is based on analysts' research of Cooper Companies and is not a guaranteed prediction by Public.com or investment advice.
Cooper Companies (COO) Analyst Forecast & Price Prediction
Start investing in Cooper Companies (COO)
Order type
Buy in
Order amount
Est. shares
0 shares